Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study

Objective To prospectively assess the utility of serum neurofilament light chain (sNfL) levels in identifying the risk to develop chemotherapy-induced cognitive impairment (CICI) in cancer patients. We also examined if sNfL can be identified as an early biomarker of CICI development. Methods We long...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Supportive care in cancer Ročník 30; číslo 2; s. 1807 - 1814
Hlavní autoři:	Argyriou, Andreas A., Karteri, Sofia, Bruna, Jordi, Mariotto, Sara, Simo, Marta, Velissaris, Dimitrios, Kalofonou, Foteini, Cavaletti, Guido, Ferrari, Sergio, Kalofonos, Haralabos P.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2022 Springer Springer Nature B.V
Témata:	Aged Antimitotic agents Antineoplastic agents Biological markers Biomarkers Breast cancer Breast Neoplasms - drug therapy Cancer Cancer patients Care and treatment Chemotherapy Clinical significance Cognition Cognitive ability Cognitive Dysfunction - chemically induced Cognitive Dysfunction - diagnosis Cognitive impairment Complications and side effects Critical incidents Female Health aspects Humans Intermediate Filaments Longitudinal studies Medical treatment Medicine Medicine & Public Health Middle Aged Multiple Sclerosis Nursing Nursing Research Oncology Oncology, Experimental Original Article Paclitaxel - adverse effects Pain Medicine Palliative care Patients Prospective Studies Rehabilitation Medicine Serum Women Biomarker Chemotherapy-induced cognitive impairment Serum neurofilament light chain Prediction
ISSN:	0941-4355, 1433-7339, 1433-7339
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!